Camila Almeida Stocco
Research Subjects
Research Interests
Camila Almeida Stocco has a total of 27 co-authors. Here are the top co-authors by number of shared publications:
- Amabily Keveny Saraiva Matsunaga1 shared publication
- Anna Clara Cândido Gomes1 shared publication
- Bruno Diniz
Federal University of São Paulo
1 shared publication - Bruno Leal Martins
Instituto Dante Pazzanese de Cardiologia
1 shared publication - Cassio Vinicius Rodrigues de Lima1 shared publication
- Daniela Alves Dantas1 shared publication
Latest Publications
- Open Access
- 25 March 2024
- Published by RGSA- Revista de Gestao Social e Ambiental in Revista de Gestão Social e Ambiental
- Vol. 18 (6) , e07952
Anesthesia and Patients With Cardiovascular Diseases: Challenges and Approaches
Objective: This article analyzes anesthesia strategies for cardiovascular patients, highlighting challenges and advances. The review evaluates the effectiveness of approaches like continuous hemodynamic monitoring and personalized plans in reducing perioperative complications. It also proposes measures to overcome implementation barriers, emphasizing the need for integrated health policies and innovative technologies to improve outcomes and reduce mortality. Theoretical Framework: Effective management of anesthesia in patients with cardiovascular diseases is crucial due to the increasing global prevalence of these conditions and their association with severe complications such as myocardial infarction, heart failure, and thromboembolic events. Method: A narrative literature review was conducted using major scientific databases to collect articles on anesthesia management for cardiovascular patients. Key studies were evaluated to measure the effectiveness of continuous hemodynamic monitoring and personalized plans. Specific keywords helped identify research on challenges and advances, allowing for synthesis of effective strategies and identification of implementation gaps. Results and Discussion: The review found that continuous hemodynamic monitoring and personalized anesthesia plans reduce perioperative complications in cardiovascular patients, significantly decreasing myocardial infarction, heart failure, and thromboembolic events. Implementation barriers include limited access to specialized services and managing patients with multiple comorbidities. Improving access to specialized care, continuously training healthcare professionals, and developing integrated policies and innovative technologies are essential for better diagnosis, treatment, and outcomes, reducing perioperative mortality.
- 25 March 2024
- Published by RGSA- Revista de Gestao Social e Ambiental in Revista de Gestão Social e Ambiental
- Vol. 18 (6) , e07952
Open AccessAnesthesia and Patients With Cardiovascular Diseases: Challenges and Approaches
Objective: This article analyzes anesthesia strategies for cardiovascular patients, highlighting challenges and advances. The review evaluates the effectiveness of approaches like continuous hemodynamic monitoring and personalized plans in reducing perioperative complications. It also proposes measures to overcome implementation barriers, emphasizing the need for integrated health policies and innovative technologies to improve outcomes and reduce mortality. Theoretical Framework: Effective management of anesthesia in patients with cardiovascular diseases is crucial due to the increasing global prevalence of these conditions and their association with severe complications such as myocardial infarction, heart failure, and thromboembolic events. Method: A narrative literature review was conducted using major scientific databases to collect articles on anesthesia management for cardiovascular patients. Key studies were evaluated to measure the effectiveness of continuous hemodynamic monitoring and personalized plans. Specific keywords helped identify research on challenges and advances, allowing for synthesis of effective strategies and identification of implementation gaps. Results and Discussion: The review found that continuous hemodynamic monitoring and personalized anesthesia plans reduce perioperative complications in cardiovascular patients, significantly decreasing myocardial infarction, heart failure, and thromboembolic events. Implementation barriers include limited access to specialized services and managing patients with multiple comorbidities. Improving access to specialized care, continuously training healthcare professionals, and developing integrated policies and innovative technologies are essential for better diagnosis, treatment, and outcomes, reducing perioperative mortality.
- Open Access
- 2 January 2024
- Published by RGSA- Revista de Gestao Social e Ambiental in Revista de Gestão Social e Ambiental
- Vol. 18 (1) , e07461
Recent Advances in Understanding and Managing Alzheimer's Disease: from Pathogenesis to Treatment
Objective: The objective of this article is to conduct a comprehensive review of recent advances in understanding the pathogenesis of Alzheimer's disease (AD) and innovations in its management, emphasizing how these developments can inform more effective therapeutic strategies. Initially, this study explores contemporary findings related to the molecular and cellular mechanisms contributing to AD pathology, including the aggregation of beta-amyloid and tau, neural inflammation, synaptic dysfunction, as well as the impact of genetic and environmental factors. Theoretical Framework: Alzheimer's disease (AD) presents itself as a growing challenge for global public health, given its rising prevalence and the significant impact on the affected individuals, their families, and the healthcare systems. Method: A systematic review was conducted using major scientific databases to collect relevant articles on recent advances in the understanding and management of Alzheimer's disease, from pathogenesis to treatment. Specific keywords were used to identify studies addressing new findings and interdisciplinary therapeutic strategies. This enabled the synthesis of effective approaches and the identification of research gaps, supporting evidence-based clinical practices. Results and Discussion: Recent research has identified novel genetic markers linked to Alzheimer's disease, enhancing early diagnosis. Studies have also demonstrated the efficacy of integrated cognitive therapies in slowing disease progression. Additionally, new pharmacological treatments targeting amyloid plaques have shown promise in clinical trials. However, challenges in uniform treatment efficacy across diverse populations highlight the need for tailored therapeutic approaches.
- 2 January 2024
- Published by RGSA- Revista de Gestao Social e Ambiental in Revista de Gestão Social e Ambiental
- Vol. 18 (1) , e07461
Open AccessRecent Advances in Understanding and Managing Alzheimer's Disease: from Pathogenesis to Treatment
Objective: The objective of this article is to conduct a comprehensive review of recent advances in understanding the pathogenesis of Alzheimer's disease (AD) and innovations in its management, emphasizing how these developments can inform more effective therapeutic strategies. Initially, this study explores contemporary findings related to the molecular and cellular mechanisms contributing to AD pathology, including the aggregation of beta-amyloid and tau, neural inflammation, synaptic dysfunction, as well as the impact of genetic and environmental factors. Theoretical Framework: Alzheimer's disease (AD) presents itself as a growing challenge for global public health, given its rising prevalence and the significant impact on the affected individuals, their families, and the healthcare systems. Method: A systematic review was conducted using major scientific databases to collect relevant articles on recent advances in the understanding and management of Alzheimer's disease, from pathogenesis to treatment. Specific keywords were used to identify studies addressing new findings and interdisciplinary therapeutic strategies. This enabled the synthesis of effective approaches and the identification of research gaps, supporting evidence-based clinical practices. Results and Discussion: Recent research has identified novel genetic markers linked to Alzheimer's disease, enhancing early diagnosis. Studies have also demonstrated the efficacy of integrated cognitive therapies in slowing disease progression. Additionally, new pharmacological treatments targeting amyloid plaques have shown promise in clinical trials. However, challenges in uniform treatment efficacy across diverse populations highlight the need for tailored therapeutic approaches.